Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Year: 2018
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Angela Moore, Lawrence J Green, Suzanne Bruce, Neil Sadick, Eduardo Tschen, Philip Werschler, Fran E Cook-Bolden, Sunil S Dhawan, Douglass Forsha, Michael H Gold, Scott Guenthner, Steven E Kempers, Leon H Kircik, Jennifer L Parish, Marta I Rendon, Phoebe Rich, Linda Stein-Gold, Stephen K Tyring, Robert A Weiss, Adnan Nasir, Carsten Schmitz, Terry I Boodhoo, Alexandre Kaoukhov, David R Berk
Institutions: George Washington University, Sadick Research Group, Academic Dermatology Associates, Premier Clinical Research (United States), Skin Specialty Dermatology (United States), Jordan Valley Dermatology, Tennessee Clinical Research Center, Associated Skin Care Specialists, Parish Dermatology, Henry Ford Health, The University of Texas Health Science Center at Houston, Maryland Dermatology Laser Skin and Vein Institute, Wake Research
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2955469733